Oral Vinorelbine Plus Concurrent Radiotherapy Show Promising Results in Unresectable NSCLC

A combination of oral vinorelbine plus concurrent radiotherapy (RT) had promising antitumor efficacy in patients with unresectable stage III non–small cell lung cancer (NSCLC) who had previously received neoadjuvant chemoimmunotherapy (NACIT)…